Who owns SENSEI BIOTHERAPEUTICS INC?
- Ticker: SNSE
- CUSIP Number: 81728a108
Tip: Access positions for across all investors
Analyze quarterly positions in Sensei Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sensei Biotherapeutics stock
Who bought or sold SENSEI BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Newtyn Management | 1.6M | $1.1M | -13% | Dec 2023 |
|
| Vanguard Group | 574k | $397k | 0% | Dec 2023 |
|
| Duquesne Family Office | 100k | $69k | 0% | Dec 2023 |
|
| Bank of America Corporation | 91k | $63k | 0% | Dec 2023 |
|
| Millennium Management | 38k | $27k | -33% | Dec 2023 |
|
| Citadel Advisors | 26k | $18k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 19k | $13k | -2% | Dec 2023 |
|
| Leo Wealth | 15k | $10k | 100% | Dec 2023 |
|
| Raymond James & Associates | 14k | $9.7k | 0% | Dec 2023 |
|
| Deuterium Capital Management | 11k | $7.6k | 0% | Dec 2023 |
|
| Two Sigma Investments | 10k | $7.0k | -6% | Dec 2023 |
|
| Banque Cantonale Vaudoise | 3.9k | $4.0k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 668.00 | $461.988800 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 538.00 | $0 | 118% | Dec 2023 |
|
| Wells Fargo & Company | 131.00 | $91.005700 | -1% | Dec 2023 |
|